← Back to Analyst Consensus 
DRIO Buy
DarioHealth Corp.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 19, 2026 | Alliance Global Partners | initiate | — → Buy | — | 41% |
| Aug 12, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| May 14, 2026 | Stifel | reiterate | Buy → Buy | — | 53% |
| May 13, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Mar 20, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| May 19, 2025 | Litchfield Hills | initiate | — → Buy | $3 | 25% |
| Mar 11, 2025 | Stifel | maintain | Buy → Buy | $2 | 53% |
| Apr 1, 2024 | Stifel | maintain | Buy → Buy | $4 | 53% |
| Aug 11, 2023 | Alliance Global Partners | maintain | Buy → Buy | $4.1 | 41% |
| Jul 25, 2023 | Stifel | maintain | Buy → Buy | $6 | 53% |
| May 12, 2023 | Craig-Hallum | maintain | Buy → Buy | $8 | 54% |
| Nov 16, 2022 | Alliance Global Partners | maintain | — → Buy | $7.5 | 41% |
| Aug 18, 2022 | Aegis Capital | maintain | — → Buy | $15 | — |
| Aug 16, 2022 | Cowen & Co. | maintain | — → Outperform | $14 | — |
| May 16, 2022 | Aegis Capital | maintain | — → Buy | $20 | — |
| May 16, 2022 | Cowen & Co. | maintain | — → Outperform | $18 | — |
| May 13, 2022 | Alliance Global Partners | upgrade | Neutral → Buy | $0 | 41% |
| Jan 26, 2022 | Aegis Capital | maintain | — → Buy | $25 | — |
| Aug 19, 2021 | Aegis Capital | maintain | — → Buy | $28 | — |
| Apr 22, 2021 | Cowen & Co. | initiate | — → Outperform | $31 | — |
| Mar 23, 2021 | Stifel | initiate | — → Buy | $30 | 53% |
| Feb 8, 2021 | Aegis Capital | maintain | — → Buy | $35 | — |
| Aug 17, 2020 | Aegis Capital | initiate | — → Buy | $25 | — |
| Jun 22, 2020 | ThinkEquity | initiate | — → Buy | $10 | — |
| May 13, 2020 | Craig-Hallum | maintain | — → Buy | $8 | 54% |
| Jun 6, 2019 | Craig-Hallum | initiate | — → Buy | $1.5 | 54% |
| Apr 9, 2018 | Chardan Capital | initiate | — → Buy | $4 | 47% |
| Aug 29, 2017 | Aegis Capital | initiate | — → Buy | $3.5 | — |
| May 9, 2016 | Rodman & Renshaw | initiate | — → Buy | $12 | 40% |
Price Target Trend
Mar 30, 2026 Latest: $13.6 Oct 24, 2026
EPS Estimates
0q $-0.51
Lo: $-0.51 Hi: $-0.51
2 analysts ▲1
+1q $-0.41
Lo: $-0.44 Hi: $-0.38
2 analysts ▲1
+1y $-1.12
Lo: $-1.46 Hi: $-0.78
2 analysts 0y $-2.46
Lo: $-2.48 Hi: $-2.45
2 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days